Cat. #157973
BR98 cell line
Cat. #: 157973
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Tissue: Lung
Disease: Cancer
Model: Tumour line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Tamar Peretz
Institute: Hadassah Medical Center; Hadasit Medical Research Services and Development Ltd.
Tool Details
*FOR RESEARCH USE ONLY
- Name: BR98 cell line
- Organism: Human
- Tissue: Lung
- Disease: Cancer
- Model: Tumour line
- Description: This is a triple negative breast cancer patient's derived cell line. Histology of invasive duct carcinoma. The line is derived from pleural effusion. The line grows as colonies in culture. When implanted to NSG mice it forms tumors. The line has a full exome sequence and can be compared to the germline exome sequence. This unique line can serve as a platform for drug screening for cancer stem cells targeted compounds in vitro and in vivo.
- Production details: The cells were derived from metastasis (pleural effusion) in a patient with invasive duct carcinoma.
Target Details
- Target: Breast Cancer
Handling
- Format: Frozen
- Growth medium: The base medium for this cell line is DMEM with 10% bovine serum.
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
Related Tools
- Related tools: BR45 cell line ; BR58 cell line
